| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06866691 | Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide | Traumatic Brain Injury | Recruiting |
| Phase 3 | |||
| NCT07234695 | LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down… | Down Syndrome | Recruiting |
| NCT06442748 | Short Versus Long-term Levetiracetam in Brain Tumors | Seizures | Recruiting |
| NCT07490769 | Levetiracetam Three Times Daily in Epilepsy | Epilepsy | Recruiting |
| NCT06907173 | Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) | Status Epilepticus | Recruiting |
| NCT07239115 | Levetiracetam for Seizure Prevention After Brain Tumor Surgery | Postoperative Seizures After Brain Tumor Surgery | Recruiting |
| Phase 2 | |||
| NCT06345495 | High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients… | Splenomegaly | Recruiting |
| NCT07477431 | Levetiracetam for Persons at Risk for Alzheimer's Disease | Hippocampal Hyperactivation | Recruiting |
| NCT07130786 | Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With… | Seizures | Recruiting |
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | Hematologic Malignancy | Recruiting |
| NCT06919926 | Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in… | Hippocampal Overactivity | Recruiting |
| Not specified | |||
| NCT03511118 | Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed… | Lactating Women on Select DOI | Recruiting |
| NCT05450978 | Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and… | Epilepsy | Recruiting |